CORC  > 湖南大学
FUT4 is involved in PD-1-related immunosuppression and leads to worse survival in patients with operable lung adenocarcinoma
Chang Liu; Zhi Li; Shuo Wang; Yibo Fan; Simeng Zhang; Xianghong Yang; Kezuo Hou; Jianhua Tong; Xuejun Hu; Xiaonan Shi
刊名Journal of Cancer Research and Clinical Oncology
2019
卷号Vol.145 No.1页码:65-76
关键词FUT4 Lung adenocarcinoma PD-1 Prognosis Survival
ISSN号0171-5216;1432-1335
URL标识查看原文
公开日期[db:dc_date_available]
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4607151
专题湖南大学
作者单位1.Department of Medical Oncology,The First Hospital of China Medical University,Shenyang,China
2.Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province,The First Hospital of China Medical University,Shenyang,China
3.Department of Pathology,Shengjing Hospital of China Medical University,Shenyang,China
4.Medical Research Center,The Fourth Hospital of China Medical University,Shenyang,China
5.Drug Clinical Trial Institution,The First Hospital of China Medical University,Shenyang,China
6.Department of Respiratory and Infectious Disease of Geriatrics,The First Hospital of China Medical University,Shenyang,China
推荐引用方式
GB/T 7714
Chang Liu,Zhi Li,Shuo Wang,et al. FUT4 is involved in PD-1-related immunosuppression and leads to worse survival in patients with operable lung adenocarcinoma[J]. Journal of Cancer Research and Clinical Oncology,2019,Vol.145 No.1:65-76.
APA Chang Liu.,Zhi Li.,Shuo Wang.,Yibo Fan.,Simeng Zhang.,...&Xiujuan Qu.(2019).FUT4 is involved in PD-1-related immunosuppression and leads to worse survival in patients with operable lung adenocarcinoma.Journal of Cancer Research and Clinical Oncology,Vol.145 No.1,65-76.
MLA Chang Liu,et al."FUT4 is involved in PD-1-related immunosuppression and leads to worse survival in patients with operable lung adenocarcinoma".Journal of Cancer Research and Clinical Oncology Vol.145 No.1(2019):65-76.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace